Status:
ACTIVE_NOT_RECRUITING
Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder
Lead Sponsor:
Asad Ullah Jan
Collaborating Sponsors:
CMH Nowshera
Conditions:
PTSD - Post Traumatic Stress Disorder
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This randomized controlled trial investigates the comparative effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy and selective serotonin reuptake inhibitors (SSRIs) in foste...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD) based on DSM-5 criteria
- Willingness to participate and provide informed consent
- Ability to comply with study procedures
Exclusion
- Current diagnosis of psychotic disorder, bipolar disorder, or severe major depressive episode with psychotic features
- Active substance use disorder within the past 6 months
- Severe cognitive impairment or inability to complete study assessments
Key Trial Info
Start Date :
May 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06957210
Start Date
May 6 2025
End Date
December 31 2025
Last Update
July 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Combined Military Hospital
Nowshera, KPK, Pakistan, 25770
2
Department of Psychiatry, Combined Military Hospital Nowshera
Nowshera, KPK, Pakistan, 25770